China's Center For Drug Evaluation Remakes Itself To Enter New Era Of Transparency, Speed Up Approvals
This article was originally published in The Pink Sheet Daily
Although China has made some progress, it still takes at least eight to nine months to get clinical trial approval there.
You may also be interested in...
SHANGHAI- Texas-based South Texas Accelerated Research Therapeutics recently announced that it will partner with Shanghai-based venture capital fund Cenova Ventures to form a joint venture to conduct early-stage oncology trials for pharma companies on both sides of the Pacific
SHANGHAI - China's slow drug approvals, which can take as long as two years, are expected to speed up considerably in the Chinese Year of the Rabbit. China's State FDA is expected to focus on new drug approvals this year in an attempt to get through its backlog of approval registrations
SEOUL - Korea FDA is gearing up to release guidelines on Phase 0 clinical trials in the first half of next year under its broader ambition to draw more early-stage clinical trials to the country